These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8547442

  • 1. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
    Heilig M, Sjögren M, Blennow K, Ekman R, Wallin A.
    Biol Psychiatry; 1995 Aug 15; 38(4):210-6. PubMed ID: 8547442
    [Abstract] [Full Text] [Related]

  • 2. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease.
    Jolkkonen J, Hartikainen P, Soikkeli R, Bissette G, Nemeroff C, Riekkinen P.
    Neuropeptides; 1991 Jun 15; 19(2):97-102. PubMed ID: 1682848
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F.
    Depress Anxiety; 1998 Jun 15; 8(2):71-9. PubMed ID: 9784981
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX.
    Chin Med J (Engl); 2004 Aug 15; 117(8):1161-4. PubMed ID: 15361288
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
    Boban M, Grbić K, Mladinov M, Hof PR, Süssmair C, Ackl N, Stanić G, Bader B, Danek A, Simić G.
    Coll Antropol; 2008 Jan 15; 32 Suppl 1():31-6. PubMed ID: 18405055
    [Abstract] [Full Text] [Related]

  • 8. Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
    Bibl M, Esselmann H, Mollenhauer B, Weniger G, Welge V, Liess M, Lewczuk P, Otto M, Schulz JB, Trenkwalder C, Kornhuber J, Wiltfang J.
    J Neurochem; 2007 Oct 15; 103(2):467-74. PubMed ID: 17662050
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
    Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LF.
    Neurosci Lett; 2007 Oct 15; 383(1-2):12-6. PubMed ID: 15936505
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY and GHRH in obese and normal weight subjects.
    Brunani A, Invitti C, Dubini A, Piccoletti R, Bendinelli P, Maroni P, Pezzoli G, Ramella G, Calogero A, Cavagnini F.
    Int J Obes Relat Metab Disord; 1995 Jan 15; 19(1):17-21. PubMed ID: 7719386
    [Abstract] [Full Text] [Related]

  • 11. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
    Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K.
    Acta Neurol Scand; 2004 Aug 15; 110(2):124-7. PubMed ID: 15242421
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin.
    Nemeroff CB, Bissette G, Akil H, Fink M.
    Br J Psychiatry; 1991 Jan 15; 158():59-63. PubMed ID: 1673078
    [Abstract] [Full Text] [Related]

  • 13. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.
    Edvinsson L, Minthon L, Ekman R, Gustafson L.
    Dementia; 1993 Jan 15; 4(3-4):167-71. PubMed ID: 8401787
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of neuropeptides in Alzheimer's disease.
    Proto C, Romualdi D, Cento RM, Spada RS, Di Mento G, Ferri R, Lanzone A.
    Gynecol Endocrinol; 2006 Apr 15; 22(4):213-8. PubMed ID: 16723308
    [Abstract] [Full Text] [Related]

  • 15. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Nilsson CL, Brinkmalm A, Minthon L, Blennow K, Ekman R.
    Peptides; 2001 Dec 15; 22(12):2105-12. PubMed ID: 11786197
    [Abstract] [Full Text] [Related]

  • 16. [Neuropeptides in Alzheimer's disease].
    Jiménez-Corral C, Morán-Sánchez JC, Alonso-Navarro H.
    Rev Neurol; 2001 Dec 15; 42(6):354-9. PubMed ID: 16575772
    [Abstract] [Full Text] [Related]

  • 17. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
    Brundin L, Björkqvist M, Petersén A, Träskman-Bendz L.
    Eur Neuropsychopharmacol; 2007 Sep 15; 17(9):573-9. PubMed ID: 17346943
    [Abstract] [Full Text] [Related]

  • 18. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S, Rauk A.
    Med Hypotheses; 2005 Sep 15; 65(1):123-37. PubMed ID: 15893129
    [Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.
    Bibl M, Mollenhauer B, Esselmann H, Schneider M, Lewczuk P, Welge V, Gross M, Falkai P, Kornhuber J, Wiltfang J.
    Dement Geriatr Cogn Disord; 2008 Sep 15; 25(3):256-65. PubMed ID: 18270488
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptides in neurological disease.
    Beal MF, Martin JB.
    Ann Neurol; 1986 Nov 15; 20(5):547-65. PubMed ID: 2947536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.